000			03578nam a2200409 i 4500
999			_c11451 _d11451
001			11451
003			ES-MaUEC
005			20210713040331.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			180731s2018 gw | o |||| 0|eng d
020			_a9783319928029
024	7		_a10.1007/978-3-319-92802-9 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
041	0		_aeng
050		4	_aRM847 _b.H97 2018 EB
245	1	0	_aHypofractionated and Stereotactic Radiation Therapy : _bA Practical Guide _cedited by Orit Kaidar-Person, Ronald Chen
264		1	_aCham, Switzerland _bSpringer _c2018
300			_a1 recurso en línea (XXVII, 406 páginas) _b51 ilustraciones, 40 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aMedicine (Springer-11650)
505	0		_aBiological Rationale for Hypofractionated Radiation Therapy -- Modern Physics and Technological Developments for Delivery of Hypofractionated Radiation Therapy -- Prostate Cancer -- Breast Cancer -- Lung Cancer -- Skin Cancer -- Central Nervous System Tumors -- Gastrointestinal Cancer -- Gynecologic Cancer -- Pediatric Cancer -- Palliation. .
520	3		_aThis handbook summarizes the data and techniques for hypofractionation and stereotactic radiation in a clinically-accessible way. Hypofractionated radiation therapy, which consists of larger-dose radiation treatments that are given over a shorter time period compared to conventional radiation fraction sizes, is used to treat a variety of cancers, including prostate, breast, lung, and colorectal. Conventional radiation therapy and hypofractionated radiation therapy have different effectiveness rates for cancer treatment and have different impacts on normal tissues in terms of causing toxicity. There is a significant and growing body of literature on the use of different dosing regimens to treat a variety of cancers and radiation oncologists need to keep up with the various dosing schedules, the effect of each regimen on cancer control in different cancers, and how the different schedules affect each organ in terms of toxicity. The book thus provides concise information ranging from commonly-used dose-fractionation schemes for hypofractionated and stereotactic body radiotherapy to simulation and treatment specifications to published safety and efficacy data. Chapters additionally examine the biological rationales for the efficacy of hypofractionated radiation; present clinical studies that demonstrate the efficacy and safety of hypofractionated radiation treatment in a variety of cancers; and describe the advances in technology that have allowed hypofractionated radiation to be safely given. This is an ideal guide for radiation oncology clinicians and trainees. .
988			_aEBSPRINGER_2018
650		7	_2embne _9139979 _aRadioterapia
700	1		_aKaidar-Person, Orit. _eeditor literario
700	1		_aChen, Ronald. _eeditor literario _0http://viaf.org/viaf/208366656
710	2		_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _0http://viaf.org/viaf/148105729 _9106996
776	0	8	_iEdición impresa: _z9783319928005
776	0	8	_iEdición impresa: _z9783319928012
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-92802-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942			_2lcc _cLE _n0
998			_db _zSI